342 related articles for article (PubMed ID: 15590760)
1. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.
Dragon-Durey MA; Loirat C; Cloarec S; Macher MA; Blouin J; Nivet H; Weiss L; Fridman WH; Frémeaux-Bacchi V
J Am Soc Nephrol; 2005 Feb; 16(2):555-63. PubMed ID: 15590760
[TBL] [Abstract][Full Text] [Related]
2. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.
Dragon-Durey MA; Blanc C; Garnier A; Hofer J; Sethi SK; Zimmerhackl LB
Semin Thromb Hemost; 2010 Sep; 36(6):633-40. PubMed ID: 20865640
[TBL] [Abstract][Full Text] [Related]
3. Anti-factor H autoantibodies assay.
Dragon-Durey MA; Blanc C; Roumenina LT; Poulain N; Ngo S; Bordereau P; Frémeaux-Bacchi V
Methods Mol Biol; 2014; 1100():249-56. PubMed ID: 24218265
[TBL] [Abstract][Full Text] [Related]
4. The autoimmune disease DEAP-hemolytic uremic syndrome.
Skerka C; Zipfel PF; Müller D; Micklisch S; Riedl M; Zimmerhackl LB; Hofer J
Semin Thromb Hemost; 2010 Sep; 36(6):625-32. PubMed ID: 20865639
[TBL] [Abstract][Full Text] [Related]
5. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
Dragon-Durey MA; Frémeaux-Bacchi V
Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
[TBL] [Abstract][Full Text] [Related]
6. Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome.
Le Quintrec M; Zuber J; Noel LH; Thervet E; Frémeaux-Bacchi V; Niaudet P; Fridman WH; Legendre C; Dragon-Durey MA
Am J Transplant; 2009 May; 9(5):1223-9. PubMed ID: 19422347
[TBL] [Abstract][Full Text] [Related]
7. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
Józsi M; Strobel S; Dahse HM; Liu WS; Hoyer PF; Oppermann M; Skerka C; Zipfel PF
Blood; 2007 Sep; 110(5):1516-8. PubMed ID: 17495132
[TBL] [Abstract][Full Text] [Related]
8. A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations.
Matsukuma E; Gotoh Y; Kuroyanagi Y; Yamada T; Iwasa M; Yamakawa S; Nagai T; Takagi N; Mae H; Iijima K; Bresin E
Clin Exp Nephrol; 2011 Apr; 15(2):269-74. PubMed ID: 21271273
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
10. Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome.
Blanc C; Roumenina LT; Ashraf Y; Hyvärinen S; Sethi SK; Ranchin B; Niaudet P; Loirat C; Gulati A; Bagga A; Fridman WH; Sautès-Fridman C; Jokiranta TS; Frémeaux-Bacchi V; Dragon-Durey MA
J Immunol; 2012 Oct; 189(7):3528-37. PubMed ID: 22922817
[TBL] [Abstract][Full Text] [Related]
11. Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.
Strobel S; Abarrategui-Garrido C; Fariza-Requejo E; Seeberger H; Sánchez-Corral P; Józsi M
Kidney Int; 2011 Aug; 80(4):397-404. PubMed ID: 21677636
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.
Dragon-Durey MA; Sethi SK; Bagga A; Blanc C; Blouin J; Ranchin B; André JL; Takagi N; Cheong HI; Hari P; Le Quintrec M; Niaudet P; Loirat C; Fridman WH; Frémeaux-Bacchi V
J Am Soc Nephrol; 2010 Dec; 21(12):2180-7. PubMed ID: 21051740
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
15. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.
Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Guo WY; Wang SX; Yu F; Zhao MH;
Pediatr Nephrol; 2017 May; 32(5):811-822. PubMed ID: 28035470
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristies of atypical hemolytie uremic syndrome associated with H factor antibody in children].
Guan N; Liu X; Yao Y; Yang J; Wang F; Xiao H; Ding J; Zhao M; Yu F; Wang F
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):223-6. PubMed ID: 24824395
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.
Puraswani M; Khandelwal P; Saini H; Saini S; Gurjar BS; Sinha A; Shende RP; Maiti TK; Singh AK; Kanga U; Ali U; Agarwal I; Anand K; Prasad N; Rajendran P; Sinha R; Vasudevan A; Saxena A; Agarwal S; Hari P; Sahu A; Rath S; Bagga A
Front Immunol; 2019; 10():1282. PubMed ID: 31231391
[No Abstract] [Full Text] [Related]
18. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator.
Nozal P; Garrido S; Alba-Domínguez M; Espinosa L; Peña A; Córdoba SR; Sánchez-Corral P; López-Trascasa M
Mol Immunol; 2014 Apr; 58(2):194-200. PubMed ID: 24378252
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and classification of hemolytic uremic syndrome: the Hungarian experience.
Reusz GS; Szabó AJ; Réti M; Györke Z; Szilágyi Á; Farkas P; Prohászka Z
Transplant Proc; 2011 May; 43(4):1247-9. PubMed ID: 21620101
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in haemolytic uraemic syndrome (HUS).
Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
